Management
Craig H. Misrach, M.B.A., C.P.A. – President and Chief Executive Officer
Craig H. Misrach is the President and Chief Executive Officer of Freedom Meditech and has over 10 years of finance experience with start-up and midsize organizations. Prior to Freedom Meditech, Mr. Misrach was the President and Chief Operating Officer of EyeChem, a developmental stage diabetes medical device company focused on the commercialization of an eye-related blood glucose measuring and monitoring system. At EyeChem, Mr. Misrach crafted and executed the financing, operating, and marketing strategies of the organization while simultaneously overseeing the contract manufacturing and product development activities of the company. Mr. Misrach was successful in obtaining initial start-up capital and infrastructure support for the organization.
Prior to EyeChem, Mr. Misrach was Controller and Assistant Vice President of Silvergate Capital Corporation, a $500M asset-based diversified finance organization. At Silvergate, Mr. Misrach was the primary liaison for executive management regarding the revenue and expense activities of the organization and gained extensive operational and management experience during a two year period of fast-paced corporate growth from 28 to 79 employees. Silvergate was a client of Mr. Misrach at Deloitte and Touche, where he was the Lead Senior Accountant for a $60M IPO and audited various biotechnology, medical device, and healthcare companies.
Mr. Misrach is a Certified Public Accountant (C.P.A.) in the State of California and has a B.S in Accounting and Finance from Indiana University. Mr. Misrach also has an M.B.A. in General Management and Entrepreneurship & Venture Capital from the Darden Graduate School of Business at the University of Virginia.
Brent D. Cameron Ph.D. – Chief Scientific Officer
Dr. Brent D. Cameron is currently the Director and Associate Professor of Bioengineering at the University of Toledo. His current efforts are focused on developing methods to allow for noninvasive physiological glucose measurement. Over the past 10 years, Dr. Cameron has written several papers and had his research findings published in reputable diabetes magazines for his work using polarized light to monitor glucose levels within the aqueous humor of the eye.
Other investigations of Dr. Cameron include the development of smart spinal disc implants and the development and testing of a device used in photo-biotherapy. Dr. Cameron is also working on a technique which employs the use of surface enhanced Raman spectroscopy (SERS) for cytochrome P450s characterization towards the development of therapeutic drug monitoring.
Dr. Cameron has a B.S. and M.S. in Bioengineering from Texas A&M University. Dr. Cameron obtained his Ph.D. in Biomedical Engineering from Texas A&M University. A detailed listing of Dr. Cameron’s published papers and grants awarded can be provided upon request.
Brian Catanzaro, Ph.D. – VP of Product Development, Lead Optical Engineer
Brian Catanzaro, Ph.D. is an independent consultant in the field of optical engineering. He holds a Ph.D. in Applied Physics from the Electrical and Computer Engineering Department of University of California, San Diego as well as a B.S. degree in Applied Physics from the California Institute of Technology. Dr. Catanzaro has published numerous papers in various fields including hyperspectral instrumentation, biological sensors, biomedical devices, stable structures for space borne instruments, and optical metrology. He has been active in the aerospace, telecommunications, microlithography, semiconductor fabrication, head mounted display, military sensor, biological sensor, and biomedical device industries. His expertise includes product development in areas of advanced optical technology. This includes optical design, optical analysis, prototyping, and testing of optical systems. In addition, he is well versed in mechanical and thermal analyses in support of opto-mechanical system design, analysis, and fabrication.
Dr. Catanzaro has been involved with several biotech instruments and medical devices. Dr. Catanzaro has designed genetic array sequencing, using confocal instruments and optical resonator technologies. He has also designed and developed the optics, opto-mechanics, and opto-electronics for medical devices that address: stroke therapy, non-invasive glucose measurement, drug infusion, ocular measurements for contact lens fitting, and stem cell sorting.